Company Filing History:
Years Active: 2016-2023
Title: **Olivia Jennifer Razo: Pioneering Innovations in Antibody Technology**
Introduction
Olivia Jennifer Razo, an accomplished inventor based in Newark, CA, has made significant contributions to the field of biotechnology, particularly in the development of innovative antibody technologies. With three patents to her name, Razo has been instrumental in advancing therapeutic and diagnostic solutions that target important biological markers.
Latest Patents
Among Olivia's notable inventions are her latest patents, which focus on bispecific anti-CD3 antibodies and bispecific activatable anti-CD3 antibodies. These inventions involve antibodies that specifically bind to CD3, an important component in T-cell activation and signaling. The methods associated with these antibodies offer a range of applications in therapeutic, diagnostic, and prophylactic contexts, providing new avenues for treating various conditions by enhancing immune responses.
Career Highlights
Throughout her career, Olivia has collaborated with renowned biotech companies. She started her professional journey with CytomX Therapeutics, Inc., where she honed her skills in biotherapeutics. Later, she continued her work at AbbVie Biotherapeutics Inc., contributing to the development of groundbreaking antibody therapies. Her efforts have not only advanced the scientific community's understanding of antibody functionality but have also led to practical applications that could benefit numerous patients.
Collaborations
In her journey, Olivia has worked alongside prominent colleagues such as Bryan Allen Irving and Sherry Lynn La Porte. These collaborations have undoubtedly enriched her research and development endeavors, fostering an environment of innovation and excellence within her teams.
Conclusion
Olivia Jennifer Razo stands out as a formidable inventor in the field of antibody technology. Her patents, showcasing her innovative approaches to biotherapeutics, highlight her commitment to improving healthcare solutions. As the medical and scientific communities continue to explore the potential of her inventions, Olivia's contributions will play an essential role in shaping the future of therapeutic antibody applications.